Renaissance Technologies
LYRA

Renaissance Technologies’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Renaissance Technologies’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,018
Closed -$317K – 3782
2024
Q1 		$317K Buy
1,018
+140
+16% +$37.3K ﹤0.01% 3070
2023
Q4 		$230K Sell
878
-118
-12% -$21.4K ﹤0.01% 3085
2023
Q3 		$195K Sell
996
-424
-30% -$75.8K ﹤0.01% 3099
2023
Q2 		$292K Buy
1,420
+463
+48% +$64.3K ﹤0.01% 3137
2023
Q1 		$96K Buy
957
+213
+29% +$26.4K ﹤0.01% 3503
2022
Q4 		$117K Sell
744
-56
-7% -$11.1K ﹤0.01% 3570
2022
Q3 		$200K Sell
800
-20
-2% -$5.92K ﹤0.01% 3386
2022
Q2 		$232K Buy
820
+470
+134% +$128K ﹤0.01% 3581
2022
Q1 		$70K Sell
350
-690
-66% -$152K ﹤0.01% 3852
2021
Q4 		$227K Buy
+1,040
New +$334K ﹤0.01% 3464

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies's LYRA Position: Q2 2024 in Review

Renaissance Technologies sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2024, closing a stake of 1,018 shares — an estimated $317K sold.

Renaissance Technologies first reported a position in LYRA in Q4 2021 and held it in 10 quarters. The position peaked at $317K in Q1 2024. 51 funds tracked by Wall St. Rank hold LYRA as of Q2 2024.

  • Renaissance Technologies reported no remaining LYRA THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
  • Renaissance Technologies sold 1,018 LYRA THERAPEUTICS INC shares in Q2 2024, an estimated $317K.
  • Renaissance Technologies first reported a position in LYRA THERAPEUTICS INC in Q4 2021 and held it in 10 quarters.
  • Renaissance Technologies's LYRA THERAPEUTICS INC position peaked at $317K in Q1 2024.
  • 51 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.